免疫タンパク質診断検査市場規模、シェア、成長分析、検査別、用途別、技術別、最終用途別、流通チャネル別、地域別 - 2024～2031年産業別予測

免疫タンパク質診断検査の世界市場規模は2022年に90億米ドルと評価され、2023年の96億7,000万米ドルから2031年には172億6,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは7.5%で成長する見通しです。

世界の免疫タンパク質診断検査市場は、感染症や慢性疾患の有病率の上昇に加え、疾患の早期発見の重要性に対する意識の高まりに後押しされ、著しい成長を遂げています。特に酵素結合免疫吸着測定法（ELISA）や化学発光免疫測定法のような診断手法における主要な技術進歩は、タンパク質ベースの診断の精度と効率を著しく向上させています。人口の高齢化とヘルスケア支出の増加が、この拡大をさらに後押ししています。とはいえ、コスト面での制約や厳しい規制基準といった潜在的な障壁が市場の進展を妨げる可能性もあります。全体として、正確で迅速な診断ツールに対する需要の高まりが、効果的な疾病管理と十分な情報に基づいた治療方針の決定に不可欠な市場の勢いを促進しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

免疫タンパク質診断検査市場規模：検査別およびCAGR（2024～2031年）

• 市場概要
• 補体系タンパク質診断検査
• フリーライトチェーン診断検査
• ハプトグロビン診断検査
• 免疫グロブリン診断検査
• プレアルブミン診断検査
• C反応性タンパク質（CRP）診断検査

免疫タンパク質診断検査市場規模：用途別およびCAGR（2024～2031年）

• 市場概要
• 感染症検査
• 腫瘍学検査
• 内分泌検査
• 毒性試験
• アレルギー検査
• 自己免疫疾患検査

免疫タンパク質診断検査市場規模：技術別およびCAGR（2024～2031年）

• 市場概要
• 放射免疫測定
• 酵素免疫測定法
• 化学発光アッセイ
• 免疫蛍光アッセイ
• 免疫濁度アッセイ
• 免疫タンパク質電気泳動

免疫タンパク質診断検査市場規模：最終用途別およびCAGR（2024～2031年）

• 市場概要
• 病院と診療所
• 診断検査室
• その他

免疫タンパク質診断検査市場規模：流通チャネル別およびCAGR（2024～2031年）

• 市場概要
• 直接入札
• 小売販売

免疫タンパク質診断検査市場規模およびCAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021～2023年）

主要企業プロファイル

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（USA）
• Eurofins Scientific（Luxembourg）
• Qiagen N.V.（Netherlands）
• Fujifilm Holdings Corporation（Japan）
• DiaSorin S.p.A.（Italy）
• Bio-Rad Laboratories, Inc.（USA）
• Sekisui Medical Corporation（Japan）
• Ortho Clinical Diagnostics（USA）
• Beckman Coulter, Inc.（USA）
• Myriad Genetics, Inc.（USA）
• Alere Inc.（USA）
• Quest Diagnostics Incorporated（USA）
• LabCorp（USA）
• BioMerieux SA（France）
• ARUP Laboratories（USA）
• MSD（Merck & Co., Inc.）（USA）

結論と推奨事項

Global Immunoprotein Diagnostic Testing Market size was valued at USD 9.0 billion in 2022 and is poised to grow from USD 9.67 billion in 2023 to USD 17.26 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

The global immunoprotein diagnostic testing market is witnessing remarkable growth, propelled by the rising prevalence of infectious and chronic diseases alongside enhanced awareness of the importance of early disease detection. Key technological advancements, particularly in diagnostic methodologies like enzyme-linked immunosorbent assays (ELISA) and chemiluminescent immunoassays, have significantly improved the accuracy and efficiency of protein-based diagnostics. The expansion is further supported by an aging population and rising healthcare spending. Nonetheless, potential barriers such as cost constraints and stringent regulatory standards could hinder market progress. Overall, the increasing demand for precise and rapid diagnostic tools is driving market momentum, essential for effective disease management and informed therapeutic decision-making.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunoprotein Diagnostic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunoprotein Diagnostic Testing Market Segmental Analysis

Global Immunoprotein Diagnostic Testing Market is segmented by test, application, technology, end use, distribution channel and region. Based on test, the market is segmented into complement system proteins diagnostic tests, free light chain diagnostic tests, haptoglobin diagnostic tests, immunoglobulin diagnostic tests, prealbumin diagnostic tests and c-reactive protein (CRP) diagnostic tests. Based on application, the market is segmented into infectious disease testing, oncology testing, endocrine testing, toxicology testing, allergy testing and autoimmune disease testing. Based on technology, the market is segmented into radioimmunoassay, enzyme based immunoassay, chemiluminescence assay, immunofluorescence assay, immunoturbidity assay and immunoprotein electrophoresis. Based on end use, the market is segmented into hospitals and clinics, diagnostic laboratories and others. Based on distribution channel, the market is segmented into direct tender and retail sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Immunoprotein Diagnostic Testing Market

A significant driver of the global immunoprotein diagnostic testing market is the rising incidence of chronic and infectious diseases, which is intensifying the need for precise and prompt diagnostic solutions. Immunoprotein testing is essential for the detection of various conditions, including cancer, autoimmune disorders, and infectious diseases. Moreover, increased awareness surrounding the importance of early disease identification, coupled with advancements in diagnostic technologies, is additionally propelling the growth of this market. As healthcare professionals prioritize timely interventions and accurate assessments, the demand for immunoprotein diagnostic tests continues to surge, further reinforcing the market's expansion.

Restraints in the Global Immunoprotein Diagnostic Testing Market

One of the critical challenges facing the Global Immunoprotein Diagnostic Testing market is the intricate and costly process involved in developing and implementing these tests. Creating reliable and specific immunoprotein diagnostic tests demands extensive research, development, and validation, which can be both time-consuming and resource-intensive. Additionally, the high costs associated with these tests can limit their accessibility, particularly in resource-constrained healthcare environments, thus hindering their broader adoption. This financial barrier not only affects the market's growth potential but also restricts the availability of advanced diagnostic solutions to various segments of the population, ultimately impacting overall market expansion.

Market Trends of the Global Immunoprotein Diagnostic Testing Market

The global immunoprotein diagnostic testing market is experiencing substantial growth, driven by a surge in the incidence of infectious and chronic diseases necessitating precise diagnostic solutions. Innovations in technology, particularly multiplex immunoassay platforms and point-of-care testing, are enhancing the speed and accuracy of diagnostics, fueling market expansion. The rising emphasis on personalized medicine and advancing biomarker research is bolstering the uptake of immunoprotein tests, as tailored therapies become more prevalent. Furthermore, strategic partnerships between industry leaders and research entities are fostering innovation and refining testing methodologies, positioning the market for robust growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Immunoprotein Diagnostic Testing Market Size by Test & CAGR (2024-2031)

• Market Overview
• Complement System Proteins Diagnostic Tests
• Free Light Chain Diagnostic Tests
• Haptoglobin Diagnostic Tests
• Immunoglobulin Diagnostic Tests
• Prealbumin Diagnostic Tests
• C-Reactive Protein (Crp) Diagnostic Tests

Global Immunoprotein Diagnostic Testing Market Size by Application & CAGR (2024-2031)

• Market Overview
• Infectious Disease Testing
• Oncology Testing
• Endocrine Testing
• Toxicology Testing
• Allergy Testing
• Autoimmune Disease Testing

Global Immunoprotein Diagnostic Testing Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Radioimmunoassay
• Enzyme Based Immunoassay
• Chemiluminescence Assay
• Immunofluorescence Assay
• Immunoturbidity Assay
• Immunoprotein Electrophoresis

Global Immunoprotein Diagnostic Testing Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Hospitals and Clinics
• Diagnostic Laboratories
• Others

Global Immunoprotein Diagnostic Testing Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Direct Tender
• Retail Sales

Global Immunoprotein Diagnostic Testing Market Size & CAGR (2024-2031)

• North America (Test, Application, Technology, End Use, Distribution Channel)
  • USA
  • Canada
• Europe (Test, Application, Technology, End Use, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test, Application, Technology, End Use, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test, Application, Technology, End Use, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test, Application, Technology, End Use, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Medical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARUP Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD (Merck & Co., Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations